Haematology & Blood Cancer Management
Specialized clinical care for blood malignancies including Lymphoma and Leukaemia (ALL); IV, oral, intrathecal chemotherapy & day-care protocols.
Management of Lymphomas & Leukaemias
Haematological malignancies demand specialized, rapid diagnostic confirmation and meticulous chemo-immunotherapy protocols. Dr. Kunal Jain's DM Medical Oncology training at GCRI Ahmedabad and active research background equip him with specialized expertise in managing blood cancers.
Dr. Jain served as Co-Principal Investigator on a major Phase III trial for CD20-positive Follicular Lymphoma and authored his DM Medical Oncology thesis on infection patterns during induction therapy in Acute Lymphoblastic Leukemia (ALL).
Haematological Conditions & Clinical Protocols
- Lymphoma Management (Hodgkin & Non-Hodgkin Lymphoma)Chemo-immunotherapy protocols (including Rituximab-based regimens for CD20+ Follicular and Diffuse Large B-Cell Lymphomas).
- Leukaemia Management (Acute ALL / AML & Chronic Leukaemias)Induction, consolidation, and maintenance chemotherapy, with specialized supportive care for neutropenic infection prevention.
- Intrathecal Chemotherapy (Central Nervous System Prophylaxis)Specialized administration of intrathecal chemotherapy to prevent or treat central nervous system involvement in acute leukaemias and aggressive lymphomas.
- Day-Care Infusion & Supportive CareHigh-dose & low-dose day-care chemotherapy administration, blood component transfusions, and growth factor support.
Related Clinical Research & Thesis
Read details on Dr. Jain's Phase III Follicular Lymphoma trial and DM ALL Infection Thesis.
Book a Consultation
Fill out the form below for an in-person or online oncology consultation with Dr. Kunal Jain.